secwatch / observer
8-K filed February 14, 2025, 6:59 PM ET ticker ABBV CIK 0001551152
leadership confidence high sentiment neutral materiality 0.40

AbbVie appoints CEO Robert Michael as Chairman, Gonzalez to retire July 1, 2025

AbbVie Inc.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Glenn F. Tilton

Director
ABBV · AbbVie Inc.
Effective
2025-07-01
Filed
February 14, 2025, 6:59 PM ET
Glenn F. Tilton informed the Company of his decision to retire as a director, effective July 1, 2025.
Departed

Richard A. Gonzalez

Chairman
ABBV · AbbVie Inc.
Effective
2025-07-01
Successor
Robert A. Michael
Filed
February 14, 2025, 6:59 PM ET
Mr. Gonzalez, who has served as Chairman since the Company’s formation in 2013, will retire from the Board, effective July 1, 2025.
Appointed

Robert A. Michael

Chairman of the Board
ABBV · AbbVie Inc.
Effective
2025-07-01
Filed
February 14, 2025, 6:59 PM ET
On February 13, 2025, the Board of Directors (the “Board”) of AbbVie Inc. (the “Company”) unanimously elected Robert A. Michael to succeed Richard A. Gonzalez as the Company’s Chairman, effective July 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Glenn F. Tilton departed as Director at AbbVie Inc..

Action
retire
Role
Director
Exact text from the filing
Glenn F. Tilton informed the Company of his decision to retire as a director, effective July 1, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Richard A. Gonzalez departed as Chairman at AbbVie Inc..

Action
retire
Role
Chairman
Exact text from the filing
Mr. Gonzalez, who has served as Chairman since the Company’s formation in 2013, will retire from the Board, effective July 1, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Robert A. Michael was elected as Chairman of the Board at AbbVie Inc..

Action
elected
Role
Chairman of the Board
Exact text from the filing
On February 13, 2025, the Board of Directors (the “Board”) of AbbVie Inc. (the “Company”) unanimously elected Robert A. Michael to succeed Richard A. Gonzalez as the Company’s Chairman, effective July 1, 2025.
View on SEC.gov

AbbVie Inc. filing history →

Source: SEC EDGAR
accession 0001104659-25-013467
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.